BioSpace News Archive

Business

Money on the Move: March 30-April 5

The AMR Action Fund financed two of this week’s money moves. Other moves ranged from medical devices to wearable sensor data companies. For that and more, continue reading.

April 6, 2022
·
3 min read
·
Hannah Chudleigh
Business

Takeda/Evozyne Partnership Headlines Hot Week for Gene Therapy Deals

Evozyne inked a partnership with Takeda Pharmaceutical to develop next-generation gene therapies for up to four rare disease targets. Continue reading for that and more collaboration news from this week.

April 6, 2022
·
3 min read
·
Mark Terry
Business

Global Roundup: Ginkgo/Microba Autoimmune Pact and New Parkinson’s Data

Biopharma and life sciences organizations from across the globe provide updates on their businesses and pipelines.

April 6, 2022
·
7 min read
·
Alex Keown
Drug Development

Kintor’s Antiviral Demonstrates Broad Protection in Mild to Moderate COVID-19

The data demonstrated that the drug, when given to the patients for more than seven days, offered a protection rate of 100%.

April 6, 2022
·
3 min read
·
Mark Terry
New Genomics Technology Could Power Gene Therapy in Oncology

A team of scientists from Mount Sinai was able to uncover specific tumor microenvironment (TME) regulators using a novel functional genomics technology known as Perturb-map.

April 6, 2022
·
7 min read
·
Abbey Glasure
Business

Mysterious Retro Biosciences Launches to “Increase Healthy Human Lifespan by 10 Years”

Retro Biosciences announced on Twitter that it is launching with $180 million in funding. Not much is known about the company, except that it indicates it is focused on the “cellular drives of aging.”

April 6, 2022
·
3 min read
·
Mark Terry
Genetown

The Future of Gene Editing Takes a Toolbox that Extends Beyond Cas9

Carver Biosciences is developing next-generation gene editing technology using Cas13. By editing RNA, this method makes it possible to target and then edit or destroy RNA from viruses like SARS-CoV-2.

April 6, 2022
·
3 min read
·
Gail Dutton
Drug Development

Novel Drug From Neuro-Bio Effective in a Mouse Model of Alzheimer’s Disease

Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the signs of neurodegeneration in a mouse model of Alzheimer’s disease.

April 6, 2022
·
6 min read
Gutta-percha Market – Emerging Trends and Growth Opportunity in the Global Market

Gutta percha has emerged as perhaps the most common and certainly irreplaceable endodontic filling or obturating material in dentistry.

April 6, 2022
·
5 min read
Endoscopic Channel Cleaning Brushes Market: The disposable brushes segment is expected to account for a significant share of market

Albany NY, United States: Endoscopy is a procedure that is carried out using a thin, long, flexible tube called the endoscope.

April 6, 2022
·
5 min read